Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Geinitz

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Anticancer Research|May 28, 2011
Impact of common medications on serum total prostate-specific antigen levels and risk group assignment in patients with prostate cancerCarsten Nieder, Jan Norum, Hans Geinitz
Anticancer Research|November 27, 2008
Validation of the graded prognostic assessment index for surgically treated patients with brain metastasesCarsten Nieder, Hans Geinitz, Michael Molls
World Journal of Urology|January 20, 2024
Acute and long-term toxicity in primary hypofractionated external photon radiation therapy in patients with localized prostate cancerWolfgang Lilleby, Amar Kishan, Hans Geinitz
Psychotherapie, Psychosomatik, Medizinische Psychologie|April 5, 2012
[Neurocognitive deficits in patients with malignant brain tumors]Andreas Dinkel, Hans Geinitz, Florian Ringel, et al.
Acta Oncologica (Stockholm, Sweden)|September 11, 2008
Validation of the graded prognostic assessment index for patients with brain metastasesCarsten Nieder, Kirsten Marienhagen, Hans Geinitz, et al.
Radiation Oncology (London, England)|January 4, 2013
Radiotherapy in marginal zone lymphomaKristin Deinbeck, Hans Geinitz, Bernhard Haller, et al.
Journal of Cancer Research and Therapeutics|May 7, 2011
Can current prognostic scores reliably guide treatment decisions in patients with brain metastases from malignant melanoma?Carsten Nieder, Kirsten Marienhagen, Hans Geinitz, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|June 29, 2012
Diagnosis-specific graded prognostic assessment score is valid in patients with brain metastases treated in routine clinical practice in two European countriesCarsten Nieder, Nicolaus H Andratschke, Hans Geinitz, et al.
Multiple Sclerosis and Related Disorders|August 23, 2020
Localised multiple sclerosis-like disease after irradiation of the cervicothoracic spinal cordChristian Eggers, Verena Kopatz, Wolfgang Dörr, et al.
Oncology Letters|November 2, 2013
A novel setup approach for helical tomotherapy in head and neck cancer: A case reportMarciana Nona Duma, Hans Geinitz, Severin Kampfer, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Anticancer Research|May 28, 2011
Impact of common medications on serum total prostate-specific antigen levels and risk group assignment in patients with prostate cancerCarsten Nieder, Jan Norum, Hans Geinitz
Anticancer Research|November 27, 2008
Validation of the graded prognostic assessment index for surgically treated patients with brain metastasesCarsten Nieder, Hans Geinitz, Michael Molls
World Journal of Urology|January 20, 2024
Acute and long-term toxicity in primary hypofractionated external photon radiation therapy in patients with localized prostate cancerWolfgang Lilleby, Amar Kishan, Hans Geinitz
Psychotherapie, Psychosomatik, Medizinische Psychologie|April 5, 2012
[Neurocognitive deficits in patients with malignant brain tumors]Andreas Dinkel, Hans Geinitz, Florian Ringel, et al.
Acta Oncologica (Stockholm, Sweden)|September 11, 2008
Validation of the graded prognostic assessment index for patients with brain metastasesCarsten Nieder, Kirsten Marienhagen, Hans Geinitz, et al.
Radiation Oncology (London, England)|January 4, 2013
Radiotherapy in marginal zone lymphomaKristin Deinbeck, Hans Geinitz, Bernhard Haller, et al.
Journal of Cancer Research and Therapeutics|May 7, 2011
Can current prognostic scores reliably guide treatment decisions in patients with brain metastases from malignant melanoma?Carsten Nieder, Kirsten Marienhagen, Hans Geinitz, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|June 29, 2012
Diagnosis-specific graded prognostic assessment score is valid in patients with brain metastases treated in routine clinical practice in two European countriesCarsten Nieder, Nicolaus H Andratschke, Hans Geinitz, et al.
Multiple Sclerosis and Related Disorders|August 23, 2020
Localised multiple sclerosis-like disease after irradiation of the cervicothoracic spinal cordChristian Eggers, Verena Kopatz, Wolfgang Dörr, et al.
Oncology Letters|November 2, 2013
A novel setup approach for helical tomotherapy in head and neck cancer: A case reportMarciana Nona Duma, Hans Geinitz, Severin Kampfer, et al.
Pageof 9